_id
69148e55ccc777a4e85d9b29
Ticker
PLRZ
Name
Polyrizon Ltd. Ordinary Shares
Exchange
NASDAQ
Address
5 Ha-Tidhar Street, Ra'anana, Israel, 4366507
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.polyrizon-biotech.com
Description
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Last Close
12.5
Volume
367554
Current Price
13.74
Change
-0.1
Last Updated
2026-01-06T09:18:03.757Z
Image
data:image/webp;base64,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
Ipo Date
2024-10-29T00:00:00.000Z
Market Cap
13281382
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9296666666666668
Sentiment Sources
3
Current Quarter
2025-06-30
Revenue
-
Cost Of Revenue
189000
Gross Profit
-189000
Operating Expenses
-1242.5
Operating Income
1242.5
Interest Expense
3140000
Pretax Income
-88.5
Net Income
-88.5
Eps
-0.00006132282691995881
Dividends Per Share
-
Shares Outstanding
1041677
Income Tax Expense
-
EBITDA
-1148
Operating Margin
-
Total Other Income Expense Net
-1331
Cash
15828000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
16032000
Property Plant Equipment
10000
Total Assets
18739000
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
364000
Equity
18375000
Bs_currency_symbol
USD
Depreciation
94.5
Change In Working Capital
-36
Cash From Operations
-1821000
Capital Expenditures
0
Cash From Investing
-2000
Cash From Financing
15097000
Net Change In Cash
13274000
Cf_currency_symbol
-
PE
-
PB
1.0791467036734694
ROE
-0.0004816326530612245
ROA
-0.00047227706921393884
FCF
-1821000
Fcf Percent
-
Piotroski FScore
0
Health Score
42
Deep Value Investing Score
6
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
6
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
189000
Quarters > 0 > income Statement > gross Profit
-189000
Quarters > 0 > income Statement > operating Expenses
-1242.5
Quarters > 0 > income Statement > operating Income
1242.5
Quarters > 0 > income Statement > interest Expense
3140000
Quarters > 0 > income Statement > pretax Income
-88.5
Quarters > 0 > income Statement > net Income
-88.5
Quarters > 0 > income Statement > eps
-0.00006132282691995881
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1443182
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1148
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-1331
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
15828000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
16032000
Quarters > 0 > balance Sheet > property Plant Equipment
10000
Quarters > 0 > balance Sheet > total Assets
18739000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
364000
Quarters > 0 > balance Sheet > equity
18375000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-88.5
Quarters > 0 > cash Flow > depreciation
94.5
Quarters > 0 > cash Flow > change In Working Capital
-36
Quarters > 0 > cash Flow > cash From Operations
-1821000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-2000
Quarters > 0 > cash Flow > cash From Financing
15097000
Quarters > 0 > cash Flow > net Change In Cash
13274000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.00006132282691995881
Quarters > 0 > ratios > PB
1.0791467036734694
Quarters > 0 > ratios > ROE
-0.0004816326530612245
Quarters > 0 > ratios > ROA
-0.00047227706921393884
Quarters > 0 > ratios > FCF
-1821000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-1242.5
Quarters > 1 > income Statement > operating Income
1242.5
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-88.5
Quarters > 1 > income Statement > net Income
-88.5
Quarters > 1 > income Statement > eps
-0.00006132282691995881
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1443182
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1148
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-1331
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
15828000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
16032000
Quarters > 1 > balance Sheet > property Plant Equipment
10000
Quarters > 1 > balance Sheet > total Assets
18739000
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
364000
Quarters > 1 > balance Sheet > equity
18375000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-88.5
Quarters > 1 > cash Flow > depreciation
94.5
Quarters > 1 > cash Flow > change In Working Capital
-36
Quarters > 1 > cash Flow > cash From Operations
-910.5
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
7548.5
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.00006132282691995881
Quarters > 1 > ratios > PB
1.0791467036734694
Quarters > 1 > ratios > ROE
-0.0004816326530612245
Quarters > 1 > ratios > ROA
-0.00047227706921393884
Quarters > 1 > ratios > FCF
-910.5
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
117000
Quarters > 2 > income Statement > gross Profit
-117000
Quarters > 2 > income Statement > operating Expenses
838000
Quarters > 2 > income Statement > operating Income
477.5
Quarters > 2 > income Statement > interest Expense
2000
Quarters > 2 > income Statement > pretax Income
-478.5
Quarters > 2 > income Statement > net Income
-957000
Quarters > 2 > income Statement > eps
-70.82069118626508
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
13513
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-838000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-956
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
2554000
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2653000
Quarters > 2 > balance Sheet > property Plant Equipment
10000
Quarters > 2 > balance Sheet > total Assets
5547000
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
261000
Quarters > 2 > balance Sheet > equity
5286000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-957000
Quarters > 2 > cash Flow > depreciation
117000
Quarters > 2 > cash Flow > change In Working Capital
7999
Quarters > 2 > cash Flow > cash From Operations
-810000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
29000
Quarters > 2 > cash Flow > cash From Financing
3312000
Quarters > 2 > cash Flow > net Change In Cash
2531000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-70.82069118626508
Quarters > 2 > ratios > PB
0.03512459704880817
Quarters > 2 > ratios > ROE
-18.104426787741204
Quarters > 2 > ratios > ROA
-17.252568956192537
Quarters > 2 > ratios > FCF
-810000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-477.5
Quarters > 3 > income Statement > operating Income
477.5
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-478.5
Quarters > 3 > income Statement > net Income
-478.5
Quarters > 3 > income Statement > eps
-0.03541034559313254
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
13513
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-419
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-956
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
2554000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
2653000
Quarters > 3 > balance Sheet > property Plant Equipment
10000
Quarters > 3 > balance Sheet > total Assets
5547000
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
261000
Quarters > 3 > balance Sheet > equity
5286000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-478.5
Quarters > 3 > cash Flow > depreciation
58.5
Quarters > 3 > cash Flow > change In Working Capital
4
Quarters > 3 > cash Flow > cash From Operations
-405
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
14.5
Quarters > 3 > cash Flow > cash From Financing
1656
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.03541034559313254
Quarters > 3 > ratios > PB
0.03512459704880817
Quarters > 3 > ratios > ROE
-0.009052213393870601
Quarters > 3 > ratios > ROA
-0.008626284478096269
Quarters > 3 > ratios > FCF
-405
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
118000
Annuals > 0 > income Statement > gross Profit
-118000
Annuals > 0 > income Statement > operating Expenses
1302000
Annuals > 0 > income Statement > operating Income
-1302000
Annuals > 0 > income Statement > interest Expense
3000
Annuals > 0 > income Statement > pretax Income
-1545000
Annuals > 0 > income Statement > net Income
-1545000
Annuals > 0 > income Statement > eps
-129.12661930631006
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
11965
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-1424000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-243000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2554000
Annuals > 0 > balance Sheet > short Term Investments
0
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2653000
Annuals > 0 > balance Sheet > property Plant Equipment
10000
Annuals > 0 > balance Sheet > total Assets
5547000
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
261000
Annuals > 0 > balance Sheet > equity
5286000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-1545000
Annuals > 0 > cash Flow > depreciation
118000
Annuals > 0 > cash Flow > change In Working Capital
-21000
Annuals > 0 > cash Flow > cash From Operations
-1147000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
29000
Annuals > 0 > cash Flow > cash From Financing
3668000
Annuals > 0 > cash Flow > net Change In Cash
2550000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-129.12661930631006
Annuals > 0 > ratios > PB
0.02863360764283012
Annuals > 0 > ratios > ROE
-29.228149829738932
Annuals > 0 > ratios > ROA
-27.852893455922118
Annuals > 0 > ratios > FCF
-1147000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
4000
Annuals > 1 > income Statement > gross Profit
-4000
Annuals > 1 > income Statement > operating Expenses
635000
Annuals > 1 > income Statement > operating Income
-635000
Annuals > 1 > income Statement > interest Expense
2000
Annuals > 1 > income Statement > pretax Income
-600000
Annuals > 1 > income Statement > net Income
-600000
Annuals > 1 > income Statement > eps
-0.2955188991723993
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2030327
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-631000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
35000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
4000
Annuals > 1 > balance Sheet > short Term Investments
37000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
54000
Annuals > 1 > balance Sheet > property Plant Equipment
12000
Annuals > 1 > balance Sheet > total Assets
559000
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
200000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
750000
Annuals > 1 > balance Sheet > equity
57000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-600000
Annuals > 1 > cash Flow > depreciation
4000
Annuals > 1 > cash Flow > change In Working Capital
7000
Annuals > 1 > cash Flow > cash From Operations
-537000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
505000
Annuals > 1 > cash Flow > net Change In Cash
-32000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.2955188991723993
Annuals > 1 > ratios > PB
450.59011491228074
Annuals > 1 > ratios > ROE
-1052.6315789473686
Annuals > 1 > ratios > ROA
-107.3345259391771
Annuals > 1 > ratios > FCF
-537000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
8
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
5000
Annuals > 2 > income Statement > gross Profit
-5000
Annuals > 2 > income Statement > operating Expenses
895000
Annuals > 2 > income Statement > operating Income
-895000
Annuals > 2 > income Statement > interest Expense
2000
Annuals > 2 > income Statement > pretax Income
-779000
Annuals > 2 > income Statement > net Income
-779000
Annuals > 2 > income Statement > eps
-0.5966445446085621
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1305635
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-772000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
116000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
36000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
51000
Annuals > 2 > balance Sheet > property Plant Equipment
16000
Annuals > 2 > balance Sheet > total Assets
546000
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
622000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1198000
Annuals > 2 > balance Sheet > equity
-652000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-779000
Annuals > 2 > cash Flow > depreciation
5000
Annuals > 2 > cash Flow > change In Working Capital
-344000
Annuals > 2 > cash Flow > cash From Operations
-1132000
Annuals > 2 > cash Flow > capital Expenditures
3000
Annuals > 2 > cash Flow > cash From Investing
-3000
Annuals > 2 > cash Flow > cash From Financing
648000
Annuals > 2 > cash Flow > net Change In Cash
-487000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.5966445446085621
Annuals > 2 > ratios > PB
-25.331722009202455
Annuals > 2 > ratios > ROE
119.47852760736197
Annuals > 2 > ratios > ROA
-142.67399267399267
Annuals > 2 > ratios > FCF
-1135000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
6000
Annuals > 3 > income Statement > gross Profit
-6000
Annuals > 3 > income Statement > operating Expenses
697000
Annuals > 3 > income Statement > operating Income
-703000
Annuals > 3 > income Statement > interest Expense
2000
Annuals > 3 > income Statement > pretax Income
-711000
Annuals > 3 > income Statement > net Income
-711000
Annuals > 3 > income Statement > eps
-0.16950991132319054
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
4194445
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-703000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-8000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
523000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
544000
Annuals > 3 > balance Sheet > property Plant Equipment
18000
Annuals > 3 > balance Sheet > total Assets
687000
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
690000
Annuals > 3 > balance Sheet > equity
-3000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-711000
Annuals > 3 > cash Flow > depreciation
6000
Annuals > 3 > cash Flow > change In Working Capital
29000
Annuals > 3 > cash Flow > cash From Operations
-492000
Annuals > 3 > cash Flow > capital Expenditures
18999
Annuals > 3 > cash Flow > cash From Investing
-19000
Annuals > 3 > cash Flow > cash From Financing
1024000
Annuals > 3 > cash Flow > net Change In Cash
513000
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.16950991132319054
Annuals > 3 > ratios > PB
-17686.576416666667
Annuals > 3 > ratios > ROE
23700
Annuals > 3 > ratios > ROA
-103.4934497816594
Annuals > 3 > ratios > FCF
-510999
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
38
Valuation > metrics > PE
-0.00006132282691995881
Valuation > metrics > PB
1.0791467036734694
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-0.0004816326530612245
Profitability > metrics > ROA
-0.0005520209580838324
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.019809523809523808
Risk > metrics > Interest Coverage
0.00039570063694267517
Risk > final Score
60
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
65
Prev Risks > 1
61
Prev Risks > 2
92
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T22:24:12.167Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-17
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.74
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.74
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-12-31
Earnings History > 1 > report Date
2025-03-11
Earnings History > 1 > date
2024-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-72.6
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-72.6
Earnings History > 1 > surprise Percent
-
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHedge Fund Bets: Should I buy QuickLogic Corporation stock now - 2025 Earnings Surprises & Weekly High Return Stock Opportunities baoquankhu1.vn
Read more →Investment Report: Can PLRZ benefit from deglobalization - 2025 Investor Takeaways & Technical Pattern Alert System baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Polyrizon Ltd. Ordinary Shares
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.74
EPS Estimate
0
EPS Difference
-0.74
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.